PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,628 | -0.4% | 18,832 | +1.6% | 0.00% | – |
| Q2 2023 | $116,054 | -25.9% | 18,539 | -43.6% | 0.00% | – |
| Q1 2023 | $156,713 | -10.2% | 32,854 | +63.9% | 0.00% | – |
| Q4 2022 | $174,418 | -2.0% | 20,048 | +34.1% | 0.00% | – |
| Q3 2022 | $178,000 | -28.2% | 14,946 | -14.2% | 0.00% | – |
| Q2 2022 | $248,000 | -23.2% | 17,413 | +12.2% | 0.00% | – |
| Q1 2022 | $323,000 | -76.8% | 15,515 | -74.2% | 0.00% | -100.0% |
| Q4 2021 | $1,391,000 | -21.2% | 60,210 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $1,766,000 | -13.4% | 59,246 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $2,040,000 | +18.5% | 59,730 | +14.1% | 0.00% | 0.0% |
| Q1 2021 | $1,721,000 | -30.6% | 52,332 | +29.9% | 0.00% | -50.0% |
| Q4 2020 | $2,479,000 | – | 40,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |